Abstract | BACKGROUND/AIM:
Sarcomas of the breast are extremely rare malignant tumors and comprise only 5% of all sarcomas and fewer than 1% of breast cancers. Primary osteosarcoma of the breast is histologically indistinguishable from osteosarcoma of the bone. Effective therapies of this recalcitrant disease have not yet been developed. MATERIALS AND METHODS: A patient-derived xenograft (PDX) mouse model of primary osteosarcoma of the breast was established by subcutaneous implantation of the surgical specimen, along with surrounding normal tissue. Hematoxylin and eosin (H&E) staining was performed on paraffin-embedded histological sections of the original tumor resected from the patient and from implanted tumors that grew in nude mice. RESULTS:
Tumors grew in 46 of 51 mice implanted with the original surgical specimen. The H&E-stained slides of the mouse-grown tumor and the original patient tumor matched, both showing large areas of spindle-shaped cells, characteristic of osteosarcoma. CONCLUSION:
|
Authors | Nathaniel F Wu, Justin Wu, Jun Yamamoto, Yusuke Aoki, Chihiro Hozumi, Michael Bouvet, Robert M Hoffman |
Journal | In vivo (Athens, Greece)
(In Vivo)
2021 Jul-Aug
Vol. 35
Issue 4
Pg. 1979-1983
ISSN: 1791-7549 [Electronic] Greece |
PMID | 34182472
(Publication Type: Journal Article)
|
Copyright | Copyright © 2021 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved. |
Topics |
- Animals
- Bone Neoplasms
- Disease Models, Animal
- Humans
- Mice
- Mice, Nude
- Osteosarcoma
- Xenograft Model Antitumor Assays
|